Tech Company Financing Transactions
Terrana Biosciences Funding Round
Terrana Biosciences closed a $50 million funding round on 7/1/2025. Investors included Flagship Pioneering.
Transaction Overview
Company Name
Announced On
7/1/2025
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Terrana will use RNA from benign plant viruses as a chassis to carry other pieces of cargo RNA into a plant to help it respond to threats like viruses, fungi, and insects.
Company Information
Company Status
Private & Independent
Industry
AgTech
Mailing Address
Undisclosed
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
The definitive RNA company for agriculture. All living things have a genetic foundation that speaks the language of nature. Technology has enabled us to read and write this language, driving lifesaving improvements in human health. Terrana has deployed the same approach to build the blueprint for novel, sustainable solutions for plant health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ryan Rapp
Browse more venture capital transactions:
Prev: 7/1/2025: North.Cloud venture capital transaction
Next: 7/1/2025: KERYS Software venture capital transaction
Share this article
News on VC Transactions
We report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs